2026. AI-DRIVEN DRUG TARGET IDENTIFICATION IN NEURODEGENERATION: APPLICATIONS IN ALZHEIMER’S, PARKINSON’S, AND ALS RESEARCH. Global Conference on Medical and Health Sciences. 1, 6 (Jun. 2026), 709–721.